ID
14798
Beschrijving
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT00754325
Link
https://clinicaltrials.gov/show/NCT00754325
Trefwoorden
Versies (1)
- 28-04-16 28-04-16 -
Geüploaded op
28 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Advanced Breast Cancer NCT00754325
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251 (Exclusion Criteria)
Beschrijving
pregnant or breast feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0549206 (Patient currently pregnant)
- SNOMED
- 77386006
- LOINC
- LA14670-6
- UMLS CUI [2]
- C0006147 (Breast Feeding)
- SNOMED
- 169741004
- LOINC
- LP420040-0
Beschrijving
chemotherapy regimen
Datatype
boolean
Alias
- UMLS CUI [1]
- C0392920 (Chemotherapy Regimen)
- SNOMED
- 716872004
Beschrijving
pleural or pericardial effusion
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032227 (Pleural effusion disorder)
- UMLS CUI [2]
- C0031039 (Pericardial effusion)
- SNOMED
- 373945007
- LOINC
- LP411655-6
Beschrijving
cardiac condition
Datatype
boolean
Alias
- UMLS CUI [1]
- C0018799 (Heart Diseases)
- SNOMED
- 56265001
Similar models
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
C0232970 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0031039 (UMLS CUI [2])
Geen commentaren